A nurse is caring for a child who has a penicillin allergy.
Which of the following prescriptions should the nurse verify with the provider?

Choice A rationale:

While it’s important for the client’s family to be aware of the disease and take precautions, they do not necessarily need to take medications to prevent infection. Tuberculosis (TB) is a contagious disease, but it typically requires close and prolonged contact to spread. Family members should be tested for TB, and if they test positive, then treatment would be necessary.

Choice B rationale:

This is the correct answer. A typical course of treatment for TB involves 6 to 9 months of consistent medication use. This is because TB bacteria die very slowly, and medications need to be taken for several months to ensure that all the bacteria are killed. If treatment is stopped too soon, some bacteria may survive and become resistant to the drugs.

Choice C rationale:

It’s not accurate to say that medications will need to be taken for the rest of the client’s life. While TB treatment is lengthy, it does not continue indefinitely. Once the full course of treatment is completed and the disease is cured, further medication is not typically necessary.

Choice D rationale:

The Mantoux test, also known as the tuberculin skin test, is used to determine whether a person has TB infection. However, the test can remain positive for a long time, even after successful treatment. Therefore, medications should not be taken until the Mantoux test is negative. Instead, the duration of treatment is determined by the healthcare provider based on various factors, including the patient’s response to the medication.

Choice A rationale:

Blood glucose levels are not typically affected by rifampin and pyrazinamide. These medications are primarily used to treat tuberculosis and do not have a direct impact on blood sugar levels.

Choice B rationale:

Thyroid function studies are not usually required when a patient is on rifampin and pyrazinamide. These medications do not typically affect the thyroid gland or its function.

Choice C rationale:

Liver function tests are crucial when a patient is on rifampin and pyrazinamide. Both of these medications can cause liver problems, including hepatitis. Therefore, regular monitoring of liver function is necessary to detect any potential damage early and adjust the treatment plan accordingly.

Choice D rationale:

Gallbladder studies are not typically required for patients on rifampin and pyrazinamide. These medications do not have a known direct impact on the gallbladder.